{
    "title": "AstraZeneca's Lynparza meets main goal in breast cancer study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4234790/AstraZenecas-Lynparza-meets-main-goal-breast-cancer-study.html",
    "date": "2017-02-17",
    "keywords": [
        "cancer",
        "parp",
        "breast",
        "percent",
        "drugmaker",
        "study",
        "class",
        "trial",
        "inhibitor",
        "plc",
        "goal",
        "condition",
        "worsening",
        "latestage",
        "studythe",
        "pence",
        "london",
        "stock",
        "exchange",
        "premarket",
        "trading",
        "fridaylynparza",
        "approval",
        "target",
        "revenue",
        "result",
        "profile",
        "subset",
        "combination",
        "dna",
        "cellsthe",
        "lynparza",
        "chemotherapy",
        "efficacy",
        "safety",
        "win",
        "astrazeneca",
        "validation",
        "leerink",
        "client",
        "note",
        "reporting",
        "banerjee",
        "bengaluru",
        "editing",
        "dcouto"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}